2,472
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Carbohydrate-derived fulvic acid wellness drink: its tolerability, safety and effect on disease markers in pre-ART HIV-1 positive subjects

, , & ORCID Icon
Pages 91-96 | Received 10 May 2017, Accepted 22 Oct 2017, Published online: 14 Dec 2017

References

  • Bouic PJD . HIV infection and OTC supplements: do they really have an impact? CME 2003;201(2): 60–63.
  • Biudes MF , Galato D . Self-medication in patients living with HIV/AIDS: little measured reality. Int J Pharm Sci Rev Res. 2014;25(2): 115–119.
  • Sabi R , Medlen CE . An investigation into the topical and systemic safety and efficacy of a new carbohydrate derived fulvic acid (CHD-FA) product. Unpublished results. Data on file. Pretoria: University of Pretoria; 2008.
  • Gandy JJ , Snyman JR , Medlen CE . An open observational study into the effects of oral use of Secomet V® on health-related outcomes in patients taking the product as a so called supplement for the treatment of HIV. Unpublished results. Data on file. Pretoria: University of Pretoria; 2008.
  • Gandy JJ , Meeding JP , Snyman JR , et al . Phase 1 clinical study of the acute and sub-acute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid. Clin Pharmacol. 2012;4: 7–11.
  • Snyman JR , Dekker J , Malfeld SCK , et al . Pilot study to evaluate the safety and therapeutic efficacy of topical oxifulvic acid in atopic volunteers. Drug Dev Res 2002;57: 40–43.10.1002/(ISSN)1098-2299
  • Botes ME , Dekker J , van Rensburg CEJ . Phase I trial with oral oxihumate in HIV infected patients. Drug Dev Res 2002;57: 34–39.10.1002/(ISSN)1098-2299
  • Shilajit, a scientific review [cited 2007 Jan 23]. Available from: https://examine.com/supplements/shilajit/
  • Hayes MHB et al. The search for structure: setting the scene. In: Hayes MHB , MacCarthy P , Malcom RL , Swift RS , editors. Humic substances II: in search of structure. London: Wiley; 1989.
  • Sparks DL . Environmental soil chemistry. 2nd ed. San Diego, CA : Academic Press; 2003. p. 82.
  • Cole SW . Psychosocial influences on HIV-1 disease progression: Neural, endocrine, and virologic mechanisms. Psychosom Med 2008;70(5): 562–568.10.1097/PSY.0b013e3181773bbd
  • Wilkin TJ , Gulick RM . When to start antiretroviral therapy? Clin Infect Dis. 2008;47: 1580–1586.10.1086/596321
  • Anglemyer A , Rutherford GW , Easterbrook PJ , et al . Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review. AIDS. 2014;28(Suppl 2): S105–S118.10.1097/QAD.0000000000000232
  • National AIDS Control Organisation . Antiretroviral therapy guidelines for HIV infected adults and adolescence including post-exposure prophylaxis. New Delhi: Government of India, Ministry of Health & Family Welfare; 2007 May. p. 136.
  • National AIDS Control Organisation . Antiretroviral therapy guidelines for HIV infected adults and adolescents. New Delhi: Government of India, Ministry of Health and Family Welfare; 2013 May.
  • The South African antiretroviral treatment guidelines . 2013. Department of Health: Republic of South Africa; 2013 March.
  • The use of essential drugs: eighth report of the WHO Expert Committee (including the revised Model List of Essential Drugs). WHO Technical Report Series 882. Geneva: World Health Organization; 1998. Available from: http://apps.who.int/medicinedocs/documents/s16061e/s16061e.pdf
  • WHO working party on the role of the pharmacist in self-care and self-medication; 1998. Available from: http://www.smasa.cc/standardpage.php?sitecontentid=8&menuid=61&title=Overview
  • UNAIDS . HIV and AIDS in India. In: Global AIDS Update 2016. 2016 [cited 2017 Nov 25]. Available from: http://www.avert.org/professionals/hiv-around-world/asia-pacific/india
  • Flanigan TP , Imam N , Lange N , et al . Decline of CD4 lymphocyte counts from the time of seroconversion in HIV-positive women. J Women’s Health 1992;1(3): 231–234.10.1089/jwh.1992.1.231